Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Targeting PANoptosis for the treatment of ischemic diseases from mechanisms to novel therapeutic strategies
Yujun Sun; Shenmei Wu; Jiangpeng Wu; Teng Gao; Chuanzhu Li; Jianshan Shi; Yong Liao; Xunkai Wang; Tang Deng; Guiyun JinShow moreShow less
1. Key Laboratory of Emergency and Trauma of Ministry of Education, Department of Interventional Radiology and Vascular Surgery, The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, China; 2. Department of Interventional Therapy, The Zhongshan Hospital Affiliated to Fudan University, Fudan University, Shanghai, ChinaShow moreShow less
Pulsed Low-dose-rate Radiotherapy Remodels the Tumor Immune Microenvironment and is Associated With Crosstalk Between SPP1⁺ tumor-associated macrophages and GZMK⁺ CD8⁺ T cells
Zihan Zhou; Yafang Hong; Jianhang You; Kaiqian Que; 蓝艺明; Yineng Lin; Junying Peng; Zhenyu Lin; Lanshan Li; Lu Han; B. XuShow moreShow less
1. Fujian Medical University; 2. Union Hospital; 3. Department of Oncology, Jinjiang Hospital of Traditional Chinese Medicine, Jinjiang, Fujian, China; 4. Zhangzhou Municipal Hospital of Fujian Province; 5. Department of Radiation Oncology, Putian No.95 Hospital, Putian, Fujian, China; 6. Department of Radiation Oncology, Quanzhou Binhai Hospital, Quanzhou, Fujian, China. cmuhanlu@hotmail.comShow moreShow less
Tumor cell-derived exosomes mediating hsa_circ_0001739/lncRNA AC159540.1 facilitate liver metastasis in colorectal cancer
Cai-Feng Yue; Ju-Gao Chen; Zi-Yue Li; Lai-Sheng Li; Jie-Rong Chen; Hai-Xia Xie; Bin Zhang; Yun-Miao GuoShow moreShow less
1. Department of Laboratory Medicine, Central People’s Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, People’s Republic of China; 2. Department of Oncology, Shenzhen People’s Hospital, Second Clinical Medical College of Jinan University, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, People’s Republic of China; 3. Prenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China; 4. Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China; 5. Department of Laboratory Medicine, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People’s Republic of China; 6. Department of Cardiovascular Diagnosis, Central People’s Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, People’s Republic of China; 7. Zhanjiang Institute of Clinical Medicine, Central People’s Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, People’s Republic of ChinaShow moreShow less
Urinary extracellular vesicles prevent di-(2-ethylhexyl) phthalate-induced hypospadias by facilitating epithelial–mesenchymal transition via PFN2 delivery
Shibo Zhu; Xiangliang Tang; Jin Zhang; Jinhua Hu; Xiaofeng Gao; Dian Li; Wei JiaShow moreShow less
1. Department of Pediatric Urology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaShow moreShow less
SUMOylation of RALY promotes vasculogenic mimicry in glioma cells via the FOXD1/DKK1 pathway
Shuo Cao; Di Wang; Ping Wang; Yunhui Liu; Weiwei Dong; Xuelei Ruan; Libo Liu; Yixue Xue; Tiange E; Hongda Lin; Xiaobai LiuShow moreShow less
1. Key Laboratory of Neuro-Oncology in Liaoning Province, Shenyang, China; 2. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China; 3. Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China; 4. Liaoning Medical Surgery and Rehabilitation Robot Technology Engineering Research Center, Shenyang, China; 5. Department of Neurobiology, School of Life Sciences, China Medical University, Shenyang, ChinaShow moreShow less
Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity
Silin Liu; Chongkai Fang; Chong Zhong; Jing Li; Qingzhong XiaoShow moreShow less
1. The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China; 2. Centre for Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Heart Centre, Charterhouse Square, London, UK; 3. Guangdong Provincial Clinical Research Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China; 4. Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China; 5. Faculty of Biological Sciences, University of Leeds, Leeds, UK; 6. Key Laboratory of Cardiovascular Diseases, School of Basic Medical Sciences, Guangzhou Institute of Cardiovascular Disease, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, ChinaShow moreShow less
FAQ
How long does CELL BIOLOGY AND TOXICOLOGY take to review a manuscript?
As of 2026-11-19, CrushSCI has 12 complete review records for CELL BIOLOGY AND TOXICOLOGY. The fastest paper went from submission to acceptance in 66 days (Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway, received 2023-07-10, accepted 2023-09-14); the slowest took 610 days. The average is 199.2 days and the median is 120.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
